Posted Jun. 9, 2014 at 3:10 p.m.

Premium Lock Merck to buy Idenix in $3.85 billion deal

Published: 2014-06-09 15:10:48
Updated: 2014-06-09 15:10:48

Merck  Merck

Merck said Monday it would buy Idenix Pharmaceuticals for $3.85 billion and plans to combine the company's two most promising drugs to produce a faster, more effective cure for hepatitis C....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll